Blockchain Registration Transaction Record

New Nose-to-Brain Tech Breaks Blood-Brain Barrier to Treat Alzheimer's

Oncotelic Therapeutics' nose-to-brain delivery system breaks the blood-brain barrier, targeting Alzheimer's and biodefense. Learn how this innovation reshapes CNS medicine.

New Nose-to-Brain Tech Breaks Blood-Brain Barrier to Treat Alzheimer's

This matters because the blood-brain barrier has been a major obstacle in treating Alzheimer's, brain tumors, and biodefense threats. Oncotelic's intranasal delivery platform could unlock effective therapies for millions of patients, potentially reducing the burden of neurodegenerative diseases and enhancing national security against bioweapons. It represents a shift from drug discovery to delivery innovation, offering hope where traditional approaches have failed.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x97e68c09c61ec9767068a7eba452e67f8253b47b5dfd5c8ea41cd3c106e73849
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintbake3__s-e7d4968365408fb488430131ebf980a1